ISIN | CH1238288059 |
---|---|
Valor Number | 123828805 |
Bloomberg Global ID | |
Fund Name | SYNCHRONY MARKET FUNDS - Synchrony Swiss Equity C |
Fund Provider |
Banque Cantonale de Genève
Genève, Switzerland Phone: +41 58 211 21 11 E-Mail: info@bcge.ch Web: www.bcge.ch |
Fund Provider | Banque Cantonale de Genève |
Representative in Switzerland | |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The objective of the Synchrony Swiss Equity Subfund is long term capital growth by investing in shares of the Swiss companies that make up the SPI® index. Companies are identified and selected based on their fundamentals, using a systematic stock-picking methodology. The Subfund invests at least two-thirds of its assets in shares and other securities or participation rights of companies domiciled or having a predominant amount of their business activity in Switzerland, and which are part of the SPI® index. |
Peculiarities |
Current Price * | 105.12 CHF | 01.11.2024 |
---|---|---|
Previous Price * | 103.78 CHF | 31.10.2024 |
52 Week High * | 109.02 CHF | 30.08.2024 |
52 Week Low * | 92.12 CHF | 07.11.2023 |
NAV * | 105.12 CHF | 01.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 195,276,661 | |
Unit/Share Assets *** | 44,623,874 | |
Trading Information SIX |
YTD Performance | +7.40% |
31.12.2023 - 01.11.2024
31.12.2023 01.11.2024 |
---|---|---|
1 month | -1.95% |
01.10.2024 - 01.11.2024
01.10.2024 01.11.2024 |
3 months | +0.93% |
02.08.2024 - 01.11.2024
02.08.2024 01.11.2024 |
6 months | +4.73% |
02.05.2024 - 01.11.2024
02.05.2024 01.11.2024 |
1 year | +15.51% |
01.11.2023 - 01.11.2024
01.11.2023 01.11.2024 |
2 years | +14.12% |
16.12.2022 - 01.11.2024
16.12.2022 01.11.2024 |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 13.06% | |
---|---|---|
Novartis AG Registered Shares | 9.97% | |
Roche Holding AG | 9.23% | |
ABB Ltd | 6.27% | |
UBS Group AG | 5.42% | |
Zurich Insurance Group AG | 4.54% | |
Sika AG | 4.14% | |
Givaudan SA | 3.57% | |
Compagnie Financiere Richemont SA Class A | 3.56% | |
Alcon Inc | 3.35% | |
Last data update | 30.06.2024 |
TER | 0.41% |
---|---|
TER date | 15.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.45% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |